Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Serotonin, psychedelics and psychiatry.

Carhart-Harris RL.

World Psychiatry. 2018 Oct;17(3):358-359. doi: 10.1002/wps.20555. No abstract available.

2.

Effects of psilocybin therapy on personality structure.

Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL.

Acta Psychiatr Scand. 2018 Jun 19. doi: 10.1111/acps.12904. [Epub ahead of print]

PMID:
29923178
3.

Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.

Gabay AS, Carhart-Harris RL, Mazibuko N, Kempton MJ, Morrison PD, Nutt DJ, Mehta MA.

Sci Rep. 2018 May 29;8(1):8236. doi: 10.1038/s41598-018-26656-2.

4.

The entropic brain - revisited.

Carhart-Harris RL.

Neuropharmacology. 2018 Mar 14. pii: S0028-3908(18)30117-5. doi: 10.1016/j.neuropharm.2018.03.010. [Epub ahead of print] Review.

PMID:
29548884
5.

Psychedelics and the essential importance of context.

Carhart-Harris RL, Roseman L, Haijen E, Erritzoe D, Watts R, Branchi I, Kaelen M.

J Psychopharmacol. 2018 Jul;32(7):725-731. doi: 10.1177/0269881118754710. Epub 2018 Feb 15. No abstract available.

PMID:
29446697
6.

Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.

Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J, Nutt DJ, Carhart-Harris RL.

J Affect Disord. 2018 Apr 1;230:84-86. doi: 10.1016/j.jad.2018.01.006.

PMID:
29407543
7.

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.

Roseman L, Nutt DJ, Carhart-Harris RL.

Front Pharmacol. 2018 Jan 17;8:974. doi: 10.3389/fphar.2017.00974. eCollection 2017.

8.

Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.

Lyons T, Carhart-Harris RL.

J Psychopharmacol. 2018 Jul;32(7):811-819. doi: 10.1177/0269881117748902. Epub 2018 Jan 17.

9.

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.

Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL.

Neuropharmacology. 2017 Dec 27. pii: S0028-3908(17)30639-1. doi: 10.1016/j.neuropharm.2017.12.041. [Epub ahead of print]

10.

Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD.

Atasoy S, Roseman L, Kaelen M, Kringelbach ML, Deco G, Carhart-Harris RL.

Sci Rep. 2017 Dec 15;7(1):17661. doi: 10.1038/s41598-017-17546-0.

11.

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.

Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ.

Psychopharmacology (Berl). 2018 Feb;235(2):399-408. doi: 10.1007/s00213-017-4771-x. Epub 2017 Nov 8.

12.

LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm.

Timmermann C, Spriggs MJ, Kaelen M, Leech R, Nutt DJ, Moran RJ, Carhart-Harris RL, Muthukumaraswamy SD.

Neuropharmacology. 2017 Nov 20. pii: S0028-3908(17)30506-3. doi: 10.1016/j.neuropharm.2017.10.039. [Epub ahead of print]

PMID:
29101022
13.

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.

Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL.

Psychopharmacology (Berl). 2018 Feb;235(2):459-466. doi: 10.1007/s00213-017-4754-y. Epub 2017 Oct 30.

14.

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.

Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ.

Sci Rep. 2017 Oct 13;7(1):13187. doi: 10.1038/s41598-017-13282-7.

15.

Serotonin and brain function: a tale of two receptors.

Carhart-Harris RL, Nutt DJ.

J Psychopharmacol. 2017 Sep;31(9):1091-1120. doi: 10.1177/0269881117725915. Epub 2017 Aug 31. Review.

16.

Psychedelics and connectedness.

Carhart-Harris RL, Erritzoe D, Haijen E, Kaelen M, Watts R.

Psychopharmacology (Berl). 2018 Feb;235(2):547-550. doi: 10.1007/s00213-017-4701-y. Epub 2017 Aug 10.

PMID:
28795211
17.

Psychedelics, Personality and Political Perspectives.

Nour MM, Evans L, Carhart-Harris RL.

J Psychoactive Drugs. 2017 Jul-Aug;49(3):182-191. doi: 10.1080/02791072.2017.1312643. Epub 2017 Apr 26.

PMID:
28443703
18.

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.

Carhart-Harris RL, Goodwin GM.

Neuropsychopharmacology. 2017 Oct;42(11):2105-2113. doi: 10.1038/npp.2017.84. Epub 2017 Apr 26. Review.

PMID:
28443617
19.

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.

Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD.

Sci Rep. 2017 Apr 19;7:46421. doi: 10.1038/srep46421.

20.

Psychedelics and the science of self-experience.

Nour MM, Carhart-Harris RL.

Br J Psychiatry. 2017 Mar;210(3):177-179. doi: 10.1192/bjp.bp.116.194738.

PMID:
28249943
21.

Altered Insula Connectivity under MDMA.

Walpola IC, Nest T, Roseman L, Erritzoe D, Feilding A, Nutt DJ, Carhart-Harris RL.

Neuropsychopharmacology. 2017 Oct;42(11):2152-2162. doi: 10.1038/npp.2017.35. Epub 2017 Feb 14.

22.

Question-based Drug Development for psilocybin - Authors' reply.

Carhart-Harris RL, Nutt DJ.

Lancet Psychiatry. 2016 Sep;3(9):807. doi: 10.1016/S2215-0366(16)30217-6. No abstract available.

PMID:
27568266
23.

Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI).

Nour MM, Evans L, Nutt D, Carhart-Harris RL.

Front Hum Neurosci. 2016 Jun 14;10:269. doi: 10.3389/fnhum.2016.00269. eCollection 2016.

24.

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.

Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ.

Lancet Psychiatry. 2016 Jul;3(7):619-27. doi: 10.1016/S2215-0366(16)30065-7. Epub 2016 May 17.

25.

LSD-induced entropic brain activity predicts subsequent personality change.

Lebedev AV, Kaelen M, Lövdén M, Nilsson J, Feilding A, Nutt DJ, Carhart-Harris RL.

Hum Brain Mapp. 2016 Sep;37(9):3203-13. doi: 10.1002/hbm.23234. Epub 2016 May 6.

26.

LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion.

Roseman L, Sereno MI, Leech R, Kaelen M, Orban C, McGonigle J, Feilding A, Nutt DJ, Carhart-Harris RL.

Hum Brain Mapp. 2016 Aug;37(8):3031-40. doi: 10.1002/hbm.23224. Epub 2016 Apr 29.

27.

Neural correlates of the LSD experience revealed by multimodal neuroimaging.

Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, Tagliazucchi E, Schenberg EE, Nest T, Orban C, Leech R, Williams LT, Williams TM, Bolstridge M, Sessa B, McGonigle J, Sereno MI, Nichols D, Hellyer PJ, Hobden P, Evans J, Singh KD, Wise RG, Curran HV, Feilding A, Nutt DJ.

Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):4853-8. doi: 10.1073/pnas.1518377113. Epub 2016 Apr 11.

28.

Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide.

Speth J, Speth C, Kaelen M, Schloerscheidt AM, Feilding A, Nutt DJ, Carhart-Harris RL.

J Psychopharmacol. 2016 Apr;30(4):344-53. doi: 10.1177/0269881116628430.

29.

The paradoxical psychological effects of lysergic acid diethylamide (LSD).

Carhart-Harris RL, Kaelen M, Bolstridge M, Williams TM, Williams LT, Underwood R, Feilding A, Nutt DJ.

Psychol Med. 2016 May;46(7):1379-90. doi: 10.1017/S0033291715002901. Epub 2016 Feb 5.

30.

LSD enhances the emotional response to music.

Kaelen M, Barrett FS, Roseman L, Lorenz R, Family N, Bolstridge M, Curran HV, Feilding A, Nutt DJ, Carhart-Harris RL.

Psychopharmacology (Berl). 2015 Oct;232(19):3607-14. doi: 10.1007/s00213-015-4014-y. Epub 2015 Aug 11.

31.

Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.

Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL.

Hum Brain Mapp. 2015 Aug;36(8):3137-53. doi: 10.1002/hbm.22833. Epub 2015 May 22.

PMID:
26010878
32.

Drug models of schizophrenia.

Steeds H, Carhart-Harris RL, Stone JM.

Ther Adv Psychopharmacol. 2015 Feb;5(1):43-58. doi: 10.1177/2045125314557797. Review.

33.
34.

LSD enhances suggestibility in healthy volunteers.

Carhart-Harris RL, Kaelen M, Whalley MG, Bolstridge M, Feilding A, Nutt DJ.

Psychopharmacology (Berl). 2015 Feb;232(4):785-94. doi: 10.1007/s00213-014-3714-z. Epub 2014 Sep 23.

PMID:
25242255
35.

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.

Roseman L, Leech R, Feilding A, Nutt DJ, Carhart-Harris RL.

Front Hum Neurosci. 2014 May 27;8:204. doi: 10.3389/fnhum.2014.00204. eCollection 2014.

36.

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.

Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, Chialvo DR, Nutt D.

Front Hum Neurosci. 2014 Feb 3;8:20. doi: 10.3389/fnhum.2014.00020. eCollection 2014.

37.

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity.

Carhart-Harris RL, Murphy K, Leech R, Erritzoe D, Wall MB, Ferguson B, Williams LT, Roseman L, Brugger S, De Meer I, Tanner M, Tyacke R, Wolff K, Sethi A, Bloomfield MA, Williams TM, Bolstridge M, Stewart L, Morgan C, Newbould RD, Feilding A, Curran HV, Nutt DJ.

Biol Psychiatry. 2015 Oct 15;78(8):554-62. doi: 10.1016/j.biopsych.2013.12.015. Epub 2014 Jan 10.

38.

Experienced drug users assess the relative harms and benefits of drugs: a web-based survey.

Carhart-Harris RL, Nutt DJ.

J Psychoactive Drugs. 2013 Sep-Oct;45(4):322-8.

PMID:
24377171
39.

The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories.

Carhart-Harris RL, Wall MB, Erritzoe D, Kaelen M, Ferguson B, De Meer I, Tanner M, Bloomfield M, Williams TM, Bolstridge M, Stewart L, Morgan CJ, Newbould RD, Feilding A, Curran HV, Nutt DJ.

Int J Neuropsychopharmacol. 2014 Apr;17(4):527-40. doi: 10.1017/S1461145713001405. Epub 2013 Dec 17.

PMID:
24345398
40.

Broadband cortical desynchronization underlies the human psychedelic state.

Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ.

J Neurosci. 2013 Sep 18;33(38):15171-83. doi: 10.1523/JNEUROSCI.2063-13.2013.

41.

Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.

Carhart-Harris RL, Brugger S, Nutt DJ, Stone JM.

J Psychopharmacol. 2013 Sep;27(9):771-8. doi: 10.1177/0269881113494107. Epub 2013 Jun 19.

PMID:
23784738
42.

Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.

Carhart-Harris RL, Leech R, Erritzoe D, Williams TM, Stone JM, Evans J, Sharp DJ, Feilding A, Wise RG, Nutt DJ.

Schizophr Bull. 2013 Nov;39(6):1343-51. doi: 10.1093/schbul/sbs117. Epub 2012 Oct 8.

43.

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.

Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ.

Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):2138-43. doi: 10.1073/pnas.1119598109. Epub 2012 Jan 23.

44.

Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.

Carhart-Harris RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T, Hobden P, Sharp DJ, Evans J, Feilding A, Wise RG, Nutt DJ.

Br J Psychiatry. 2012 Mar;200(3):238-44. doi: 10.1192/bjp.bp.111.103309. Epub 2012 Jan 26.

PMID:
22282432
45.

A web-based survey on mephedrone.

Carhart-Harris RL, King LA, Nutt DJ.

Drug Alcohol Depend. 2011 Oct 1;118(1):19-22. doi: 10.1016/j.drugalcdep.2011.02.011. Epub 2011 Mar 21.

PMID:
21420252
46.

The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability.

Carhart-Harris RL, Williams TM, Sessa B, Tyacke RJ, Rich AS, Feilding A, Nutt DJ.

J Psychopharmacol. 2011 Nov;25(11):1562-7. doi: 10.1177/0269881110367445. Epub 2010 Apr 15.

PMID:
20395317
47.

The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas.

Carhart-Harris RL, Friston KJ.

Brain. 2010 Apr;133(Pt 4):1265-83. doi: 10.1093/brain/awq010. Epub 2010 Feb 28. Review.

48.

Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls.

Carhart-Harris RL, Nutt DJ, Munafo MR, Christmas DM, Wilson SJ.

Psychopharmacology (Berl). 2009 Oct;206(2):187-96. doi: 10.1007/s00213-009-1595-3. Epub 2009 Jul 8.

PMID:
19585107
49.

Mourning and melancholia revisited: correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry.

Carhart-Harris RL, Mayberg HS, Malizia AL, Nutt D.

Ann Gen Psychiatry. 2008 Jul 24;7:9. doi: 10.1186/1744-859X-7-9.

50.

Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study.

Carhart-Harris RL, Nutt DJ, Munafò M, Wilson SJ.

J Psychopharmacol. 2009 May;23(3):249-57. doi: 10.1177/0269881108089599. Epub 2008 Jun 18.

PMID:
18562419

Supplemental Content

Loading ...
Support Center